Brochu S, Perreault C, Bélanger R
Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, Canada.
Exp Hematol. 1989 Oct;17(9):948-51.
Allogeneic bone marrow recipients exhibit a complex and multifactorial immunodeficiency affecting numerous effector functions for various periods of time. In order to evaluate their Fc-mediated monocyte-macrophage (MM) function we studied the clearance of IgG-coated Rh-positive erythrocytes (EA) in healthy control subjects and recipients of unmanipulated marrow. We measured the survival of radiolabeled EA prior to myeloablation and on days 0, +14, +38, +124, +368, and greater than or equal to +730 following bone marrow transplant (BMT). Simultaneously we evaluated the interaction of adherent peripheral blood monocytes (PBMs) with EA (in vitro phagocytosis and attachment). Fc-mediated function appeared normal prior to BMT despite the fact that most patients had received chemotherapy previously. We found no deficit in the Fc-dependent MM activity (in vivo and in vitro) at any time after transplantation. On the contrary we demonstrated an enhanced Fc-dependent clearance during the first month after BMT (p less than 0.001; Mann-Whitney test). These results suggest that we can expect efficient MM function to eliminate IgG-coated cells and particles in BMT recipients.
异基因骨髓移植受者表现出一种复杂的、多因素的免疫缺陷,在不同时间段影响多种效应功能。为了评估他们Fc介导的单核细胞-巨噬细胞(MM)功能,我们研究了健康对照者和未处理骨髓移植受者中IgG包被的Rh阳性红细胞(EA)的清除情况。我们在骨髓消融前以及骨髓移植(BMT)后的第0、+14、+38、+124、+368和大于或等于+730天测量了放射性标记的EA的存活情况。同时,我们评估了贴壁外周血单核细胞(PBMs)与EA的相互作用(体外吞噬和黏附)。尽管大多数患者此前接受过化疗,但在BMT前Fc介导的功能看起来正常。我们发现在移植后的任何时间,Fc依赖的MM活性(体内和体外)均无缺陷。相反,我们证实在BMT后的第一个月Fc依赖的清除增强(p<0.001;Mann-Whitney检验)。这些结果表明,我们可以预期BMT受者具有有效的MM功能来清除IgG包被的细胞和颗粒。